145 related articles for article (PubMed ID: 32344538)
1. Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy.
Parr E; Du Q; Zhang C; Lin C; Kamal A; McAlister J; Liang X; Bavitz K; Rux G; Hollingsworth M; Baine M; Zheng D
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32344538
[TBL] [Abstract][Full Text] [Related]
2. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
[TBL] [Abstract][Full Text] [Related]
4. A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters.
Luo LM; Huang BT; Chen CZ; Wang Y; Su CH; Peng GB; Zeng CB; Wu YX; Wang RH; Huang K; Qiu ZH
Front Oncol; 2021; 11():819047. PubMed ID: 35174072
[TBL] [Abstract][Full Text] [Related]
5. Utility of Radiomics for Predicting Patient Survival in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With Stereotactic Body Radiotherapy.
Wu K; Shui Y; Sun W; Lin S; Pang H
Front Oncol; 2020; 10():569435. PubMed ID: 33178598
[No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
7. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases.
Cheung BMF; Lau KS; Lee VHF; Leung TW; Kong FS; Luk MY; Yuen KK
Radiat Oncol J; 2021 Dec; 39(4):254-264. PubMed ID: 34986546
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment
Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a Prediction Model for Overall Survival after Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer Using Radiomics Analysis.
Sawayanagi S; Yamashita H; Nozawa Y; Takenaka R; Miki Y; Morishima K; Ueno H; Ohta T; Katano A
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010853
[TBL] [Abstract][Full Text] [Related]
11. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.
Cozzi L; Comito T; Fogliata A; Franzese C; Franceschini D; Bonifacio C; Tozzi A; Di Brina L; Clerici E; Tomatis S; Reggiori G; Lobefalo F; Stravato A; Mancosu P; Zerbi A; Sollini M; Kirienko M; Chiti A; Scorsetti M
PLoS One; 2019; 14(1):e0210758. PubMed ID: 30657785
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
Carloni G; Garibaldi C; Marvaso G; Volpe S; Zaffaroni M; Pepa M; Isaksson LJ; Colombo F; Durante S; Lo Presti G; Raimondi S; Spaggiari L; de Marinis F; Piperno G; Vigorito S; Gandini S; Cremonesi M; Positano V; Jereczek-Fossa BA
Radiother Oncol; 2023 Jan; 178():109424. PubMed ID: 36435336
[TBL] [Abstract][Full Text] [Related]
15. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
16. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.
Tang TY; Li X; Zhang Q; Guo CX; Zhang XZ; Lao MY; Shen YN; Xiao WB; Ying SH; Sun K; Yu RS; Gao SL; Que RS; Chen W; Huang DB; Pang PP; Bai XL; Liang TB
J Magn Reson Imaging; 2020 Jul; 52(1):231-245. PubMed ID: 31867839
[TBL] [Abstract][Full Text] [Related]
17. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
[TBL] [Abstract][Full Text] [Related]
18. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
19. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
20. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
